Table 1 Characteristics of Children that Completed the Study
Characteristic | No. (%) or Median (IQR) |
|---|---|
No. of patients | 12 (100) |
Age (years) | 10.5 (8.9 - 12.4) |
FVC (% predicted) | 107 (101.5 - 116.0) |
FEV1 (% predicted) | 108 (102.5 - 117.5) |
Height (percentile) | 36.5 (16.0 - 70.5) |
Weight (percentile) | 39.5 (27.5 - 71.5) |
BMI (percentile) | 48.5 (35.0 - 69.5) |
Genotype: | Â |
   F508del homozygous | 9 (75%) |
   F508del heterozygous | 2 (17%) |
   Other | 1 (8%) |
Routine Medications: | Â |
   Albuterol | 3 (25%) |
   rhDNase (dornase alpha) | 11 (92%) |
   Salmeterol/fluticasone | 7 (58%) |
   Azithromycin | 5 (42%) |
   Inhaled tobramycin | 2 (17%) |
Organisms cultured at screening: | Â |
   Staphylococcus aureus | 5 (42%) |
   Aspergillus fumigates | 3 (25%) |
   Normal/Mixed Respiratory Flora | 2 (17%) |
   Pseudomonas aeruginosa | 2 (17%) |
   Haemophilus influenza | 2 (17%) |
   MRSA | 1 (8%) |
   Stenotrophomonas multiphilia | 1 (8%) |
   Paecilomyces variotll | 1 (8%) |